8
Oct
2024

JSC Olainfarm

Exhibitor at CPHI Milan 2024 stand 16B50, Finished Dosage Formulations
About Us

Almost 50 years of experience in the market allows JSC Olainfarm to focus on solving urgent medical problems, striving to improve the health condition and quality of life of people.

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and anti-allergic products. The company is particularly experienced in the development and manufacture of adamantane,...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • LV
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16B50, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Amantadine Hydrochloride

    Product Amantadine Hydrochloride

    CAS: 665-66-7USP and CEP specifications

    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, a...
  • Memantine Hydrochloride

    Product Memantine Hydrochloride

    CAS: 41100-52-1USP and In-house specifications

    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health,...
  • Vildagliptin

    Product Vildagliptin

    CAS: 274901-16-5
    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial...
  • 3-Aminoquinuclidine dihydrochloride

    Product 3-Aminoquinuclidine dihydrochloride

    CAS:6530-09-2The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and anti...
  • 3-Quinuclidinol

    Product 3-Quinuclidinol

    CAS: 1619-34-7

    The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacte...